Skip to Main content Skip to Navigation
Journal articles

Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.

Abstract : BACKGROUND: The molecular subtypes of breast cancer have different axillary status. A nomogram including the interaction covariate between estrogen receptor (ER) and HER2 has been recently published (Reyal et al. PLOS One, May 2011) and allows to identify the patients with a high risk of positive sentinel lymph node (SLN). The purpose of our study was to validate this model on an independent population. METHODS: We studied 755 consecutive patients treated at Institut Curie for operable breast cancer with sentinel node biopsies in 2009. The multivariate model, including age, tumor size, lymphovascular invasion and interaction covariate between ER and HER2 status, was used to calculate the theoretical risk of positive sentinel lymph node (SLN) for all patients. The performance of the model on our population was then evaluated in terms of discrimination (area under the curve AUC) and of calibration (Hosmer-Lemeshow HL test). RESULTS: our population was significantly different from the training population for the following variables: median tumor size in mm, lymphovascular invasion, positive ER and age. The nomogram showed similar results in our population than in the training population in terms of discrimination (AUC=0.72 [0.68-0.76] versus 0.73 [0.7-0.75] and calibration (HL p=0.4 versus p=0.35). CONCLUSIONS: Despite significant differences between the two populations concerning variables which are part of the nomogram, the model was validated in our population. This nomogram is robust over time to predict the likelihood of positive SLN according to molecular subtypes defined by surrogate markers ER and HER2 determined by immunohistochemistry in clinical practice.
Document type :
Journal articles
Complete list of metadatas

Cited literature [31 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00750147
Contributor : Charlotte Ngo <>
Submitted on : Friday, November 9, 2012 - 10:04:30 AM
Last modification on : Tuesday, July 21, 2020 - 3:58:18 AM
Long-term archiving on: : Saturday, December 17, 2016 - 9:10:07 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Charlotte Ngo, Delphine Mouttet, Yann de Rycke, Fabien Reyal, Virginie Fourchotte, et al.. Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.. EJSO - European Journal of Surgical Oncology, WB Saunders, 2012, 38 (12), pp.1211-7. ⟨10.1016/j.ejso.2012.08.007⟩. ⟨inserm-00750147⟩

Share

Metrics

Record views

778